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Introduction: Several single-center studies and meta-analyses have shown that perioperative goal-directed therapy
may significantly improve outcomes in general surgical patients. We hypothesized that using a treatment algorithm
based on pulse pressure variation, cardiac index trending by radial artery pulse contour analysis, and mean arterial
pressure in a study group (SG), would result in reduced complications, reduced length of hospital stay and quicker
return of bowel movement postoperatively in abdominal surgical patients, when compared to a control group (CG).
Methods: 160 patients undergoing elective major abdominal surgery were randomized to the SG (79 patients) or
to the CG (81 patients). In the SG hemodynamic therapy was guided by pulse pressure variation, cardiac index
trending and mean arterial pressure. In the CG hemodynamic therapy was performed at the discretion of the
treating anesthesiologist. Outcome data were recorded up to 28 days postoperatively.
Results: The total number of complications was significantly lower in the SG (72 vs. 52 complications, p = 0.038). In
particular, infection complications were significantly reduced (SG: 13 vs. CG: 26 complications, p = 0.023). There
were no significant differences between the two groups for return of bowel movement (SG: 3 vs. CG: 2 days
postoperatively, p = 0.316), duration of post anesthesia care unit stay (SG: 180 vs. CG: 180 minutes, p = 0.516) or
length of hospital stay (SG: 11 vs. CG: 10 days, p = 0.929).
Conclusions: This multi-center study demonstrates that hemodynamic goal-directed therapy using pulse pressure
variation, cardiac index trending and mean arterial pressure as the key parameters leads to a decrease in
postoperative complications in patients undergoing major abdominal surgery.
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Despite high standards in surgical and anesthetic care in
Europe, the perioperative mortality rate is still higher than
expected [1]. The aim of goal-directed hemodynamic
therapy (GDT), based on the titration of fluids and ino-
tropic drugs to physiological flow-related end points, is
to reduce perioperative complications which might
even help to reduce perioperative morbidity and mor-
tality [2].
Multiple single-center studies have shown that peri-
operative GDT may significantly improve outcome, par-
ticularly in patients undergoing abdominal surgery [3-5],
but also in trauma [6,7] and orthopedic surgery [8]. All
these studies were single-center studies which makes the
meta-analysis that dealt with these highly divergent stud-
ies hard to interpret [9].
The underlying physiological rationale of GDT is that
due to improved cardiovascular function, adequate oxy-
gen supply can be maintained intraoperatively. Oxygen
debt can be avoided or, if it occurs due to rapid surgical
changes such as sudden blood loss, it can be corrected
quickly. Routine hemodynamic measurements, such as
heart rate and mean arterial pressure (MAP) remain
relatively unchanged despite reduced blood flow and are,
therefore, considered insensitive indicators of hypovol-
emia [10] or changes in cardiac index (CI) [11]. GDT is
targeted to detect hypovolemia and hypoperfusion early
in order to make a quick response possible.
Measurement of blood flow, for example, cardiac output
(CO), has traditionally been associated with the use of
additional invasive monitoring, including the pulmonary
artery catheter or using transpulmonary thermodilution,
or less invasively, with the esophageal Doppler. Recently,
less invasive devices assessing CO by pulse contour ana-
lysis based on the radial artery pressure signal have been
introduced [12-15]. Although these devices show lower
precision compared to the clinical gold standards of
thermodilution, their ability to assess changes in CO ad-
equately is promising [16]. Further, pulse pressure vari-
ation (PPV), reflecting the cyclic changes in preload
induced by mechanical ventilation, has been shown to re-
flect accurately volume responsiveness in a number of dif-
ferent high risk surgical groups, thus enabling the
avoidance of unnecessary and potentially harmful volume
loading [17-22]. GDT based on PPV has also been shown
to improve patient outcome [23,24].
We conducted this trial as a multi-center study with
the inclusion of a large variety of surgical interven-
tions and patient groups. Standard perioperative care
of abdominal surgical patients was compared with
hemodynamic management based on PPV and con-
tinuous CO trending using radial artery pulse contour
analysis. We hypothesized that following this treatment
regimen results in reduced postoperative complications(primary endpoint) and reduced length of hospital stay
(secondary endpoint).
Materials and methods
This study was conducted as a multi-center, prospective,
randomized, controlled trial between August 2011 and
May 2012. Patients were recruited in five centers: Northern
State Medical University (Arkhangelsk, Russia), University
Hospital Hamburg-Eppendorf (Hamburg, Germany),
University Hospital Schleswig-Holstein, (Kiel, Germany),
University of Szeged (Szeged, Hungary) and Hospital
Clínico Universitario de Valencia (Valencia, Spain). It
was approved by the appropriate Institutional Review
Boards of all participating centers and conforms to the
Journal’s requirements for human trials. It was regis-
tered at clinicaltrials.gov with the registration number
NCT01401283. Written informed consent was obtained
from all subjects.
Patients
Patients undergoing elective abdominal surgery includ-
ing general, gynecological and urological surgery were
recruited. Inclusion criteria were an anticipated duration
of surgery of more than 120 minutes or an estimated
blood loss of more than 20% of blood volume, American
Society of Anesthesiology (ASA) classification 2 or 3,
and an indication for an arterial line and central venous
catheter. Exclusion criteria were a planned postoperative
high-care intensive care unit stay, pregnant or lactating
woman, laparoscopic surgery and arrhythmias. For risk
evaluation, ASA classification [25] and Physiological and
Operative Severity Score for the Enumeration of Mortal-
ity and Morbidity (POSSUM) [26] were documented.
Enrollment, randomization and blinding
Patients were randomized either to the study group (SG)
or the control group (CG), using serially numbered
opaque envelopes. Patient enrollment, sequence gener-
ation and assignment to interventions were performed
by a responsible investigator of each participating study
center. Only patients were blinded to group allocation.
Care providers and investigators could not be blin-
ded due to the presence of the cardiac index trending
monitor.
Intraoperative management
Study group
Patients in the SG received basic anesthetic monitoring
by five-lead-electrocardiogram, pulse oximetry and blood
pressure cuff, at least one peripheral i.v., a central ven-
ous catheter and invasive radial arterial blood pressure
monitoring. This arterial line was additionally connected
to the cardiac index trending monitor (ProAQT, PULSION
Medical Systems SE, Munich, Germany). At the beginning
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assessment based on PPV, CI and MAP, as shown in
Figure 1a. First, preload was optimized by fluid loading
until PPV was <10%. At this point, the patient’s individual
preload optimized CI was determined and used as the
hemodynamic goal until the end of surgery. Only if this
value was below 2.5 L/min/(m2), inotropes were applied toPPV<10 %
Determination 
of optimal CI
(at least 2.5 L/min/m2
CI >2.5 L/min/m2
MAP >65 mmHg
yes
yes
a
b
Reassess
every 
15 min.
PPV <10 %
CI: Patient
individual Value,
at least 2.5 L/min/m2 
MAP >65 mmHg
yes
yes
Figure 1 Hemodynamic treatment algorithms: a) Algorithm for initial
intraoperative optimization.reach this minimum CI, serving as a safety parameter to
prevent patients from low cardiac output. If PPV and CI
were within the target range but MAP was below 65 mmHg,
vasopressors were started. After the initial assessment,
patients were reassessed every 15 minutes intraoperatively
to maintain values according to the study algorithm as
illustrated in Figure 1b. Patients were ventilated using)
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no
no
Fluids
Inotropes
Vasopressors
no
Stop if CI decreases,
consider inotropes
no
no
assessment and treatment. b) Algorithm for further
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Hemodynamic data were documented every 30 minutes,
ventilatory parameters every 60 minutes. At the beginning
and at the end of surgery blood samples were drawn for
arterial and central venous blood gas analysis. At the end
of surgery total catecholamine administration, estimated
blood loss, urine output and infused fluids were recorded.
The time between the end of surgery and extubation was
recorded.
Control group
Patients of the CG received basic anesthetic monitoring
by five-lead-electrocardiogram, pulse oximetry and blood
pressure cuff, at least one peripheral i.v., a central ven-
ous catheter and invasive radial arterial blood pressure
monitoring. Treatment of patients in the CG was en-
tirely performed at the discretion of the care-giving
anesthesiologist. Data collection and collection of blood
samples for complete blood gas analysis was identical to
that of the SG, except for PPV and CI, as patients in the
CG did not receive cardiac index trend monitoring.
Postoperative management
All patients were monitored in the post-anesthetic care
unit (PACU) until they were transferred to the ward.
Every 15 minutes MAP, central venous pressure and
heart rate were recorded. Arterial and venous blood gas
analyses were drawn immediately prior to discharge
from the PACU, and duration of stay in the PACU was
recorded in minutes.
Data on catecholamine use and on estimated blood loss,
urine output and infused fluids were obtained 24 hours
postoperatively. Return of bowel function, need for enteral
feeding, postoperative complications and duration of post-
operative hospital stay were recorded for up to 28 days
after surgery. The types and clustering of complications
were predefined in the study protocol, as described in
Additional file 1.
Endpoints
Primary endpoint
Pre-defined postoperative complications for each patient
(see Additional file 1) were recorded for up to 28 days
after surgery from the patient record and by visiting patients
on the ward by the investigators.
Secondary endpoint
Length of hospital stay in days was obtained from the
patient record.
Statistical analysis
Sample size calculation was oriented on previously
reported data in a comparable single center study of 33
patients [24]. The complication rate in this study was75% in the CG and 41% in the intervention group. We
compared those data with routinely derived data from
our study sites, pointing towards an actual complication
rate of around 40% in this patient population in our
centers. Therefore, the power analysis was on a reduc-
tion of complication rate from 40% to 20%, taking into
account a power of 80% and statistical significance of
P <0.05. This revealed a group size of 80 patients per
arm. Data were analyzed using Sigma Stat 3.5 and
SigmaPlot 10 (Systat Software Inc., San Jose, CA, USA).
For continuous data, the Kolmogorov-Smirnov tests
were performed to assess normal distribution and, where
appropriate, the data were analyzed with the Student’s
t-test. Non-parametric data were analyzed with the
Mann–Whitney U-test. Categorical data were compared
using χ2 and Fisher’s exact tests. A level of P <0.05
was defined as statistically significant. Data are given in
mean ± standard deviation or Median (interquartile
range) as appropriate. Comparison of intraoperative data
was restricted to the duration of five hours, the time at
which 75% of surgeries were finished.Results
A total of 180 patients were randomized, ranging from
17 to 43 from each of the five study centers. Twenty
patients had to be excluded from the study and/or
analysis because of various reasons, listed in Additional
file 2. Recruitment for the trial ended after the inclusion
of the required 160 patients for analysis. There were 79
patients in the SG and 81 patients in the CG in the final
analysis. Demographic data are given in Table 1. Pre-
operative risk scores, types of surgery and duration of
surgery did not differ significantly between the two
groups.
No specific complications or harm due to the use of
the hemodynamics trending monitor or to the applica-
tion of the study algorithm could be observed.Intra- and postoperative hemodynamic parameters
MAP differed significantly at 30 minutes (SG: 81.9 ± 16.4%
mmHg versus CG: 74.1 ± 15.4% mmHg, P = 0.002), 45
minutes (SG: 83.3 ± 16.2% mmHg versus CG: 74.1 ± 15.1%
mmHg, P = <0.001), 120 minutes (SG: 81.9 ± 14.7% mmHg
versus CG: 75.6 ± 14.5% mmHg, P = 0.012) and 150
minutes (SG: 79.0 ± 15.7% mmHg versus CG: 73.0 ± 14.7%
mmHg, P = 0.025) intraoperatively. These differences
are illustrated in Figure 2 and exact values are given in
Additional file 3.
Postoperatively, MAP was significantly lower in the CG
on arrival to the PACU (SG: 90.5 ± 20.4 mmHg versus
CG: 83.5 ± 16.3 mmHg, P = 0.024). There were no dif-
ferences in MAP on discharge from PACU (SG: 90.8 ±
19.0 mmHg versus CG: 88.8 ± 19.9 mmHg, P = 0.595).
Table 1 Demographic data
Control group
(n = 81)
Study group
(n = 79)
P-value
Agea (years) 65 (18.25) 63 (17) 0.765
Male: female 50: 31 47: 32 0.899
Heightb (m) 171.7 ± 9.4 170 ± 9.2 0.241
ABWb (kg) 79.2 ± 18.1 77.4 ± 20.4 0.557
PBWb (kg) 66.0 ± 10.1 64.3 ± 10.1 0.269
ASA III 33 33 0.978
POSSUM physiologicala 17 (7) 16 (5) 0.921
POSSUM operativea 17 (9) 15 (8.75) 0.067
Type of surgery
(number of patients)
Bowel 41 47 0.332
Non-bowel 40 32 0.332
Duration of surgery (minutes) 237.5 ± 109.8 221.9 ± 86.4 0.321
Data are median (IQR)a or mean ± SDb. Data were compared using Student’s
t-test, Mann–Whitney U-test, χ2-test or Fisher’s exact test as appropriate to
detect potential preoperative differences between the two groups. ABW,
actual body weight; ASA, physical status classification system by the American
Society of Anesthesiologists; PBW, predicted body weight: PBWmale = 45.5 +
0.91*(height(cm)-152.4), PBWfemale = 50 + 0.91*(height(cm)-152.4); POSSUM,
Physiological and Operative Severity Score for the Enumeration of Mortality
and Morbidity.
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Fluid balance
There were no significant differences in the net amount
of fluids administered intra- and postoperatively. Also,
urine output and blood loss did not differ between the
groups. Values are given in Table 2.Duration of
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Figure 2 Mean arterial pressure intraoperatively. * Significantly differenVasopressors and inotropes
As listed in Table 3, the number of patients receiving
vasopressors was equal between the two groups (SG: 42
patients versus CG: 42 patients, P = 0.994), 33 patients
in the SG received inotropes during surgery, compared
to none in the CG (P < 0.001). Few patients required
vasopressors postoperatively with no significant differ-
ence between the two groups (SG: five patients versus
CG: 9 patients, P = 0.502). None of the patients received
inotropes after the end of surgery.
Oxygenation
There were no differences in peripheral oxygen saturation
between the two groups before surgery (SG: 98.2 ± 1.5%
versus CG: 98.1 ± 2.7%, P = 0.307), at the end of surgery
(SG: 98.2 ± 1.9% versus CG: 98.4 ± 2.1%, P = 0.126) and
at discharge from recovery (SG: 96.7 ± 2.8% versus CG:
97.1 ± 2.5%, P = 0.440). Also, central venous saturation
did not show any statistically significant difference before
surgery (SG: 82.2 ± 8.4 versus CG: 82.8 ± 7.1%, P = 0.649),
at the end of surgery (SG: 80.9 ± 7.9 versus CG: 80.9 ± 8.0,
P = 0.977) and on discharge from the PACU (SG: 73.2 ±
8.9 versus CG: 73.0 ± 7.3, P = 0.905).
Complications
The overall number of complications was significantly
lower in the SG (52 complications versus 72 complica-
tions, P = 0.038), as illustrated in Figure 3a. Further, there
was a significant difference in the total number of patients
with complications. In the SG, 21 (26.6%) patients had at
least one complication, compared to 36 (44.4%) in the CG
(P = 0.028), as depicted in Figure 3b. Surgery [minutes]
150 180 210 240 270 300
Control group
Study group
*
t between control group and study group (P < 0.05).
Table 2 Fluids intra- and postoperatively
Control group (n = 81) Study group (n = 79) P-value
Fluids intraoperatively (ml)
Blood loss 704.4 ± 889.6 668.2 ± 676.6 0.773
Urine output 462.0 ± 473.4 414.4 ± 376.4 0.501
Crystalloids + Colloids 3,404.9 ± 1,694.2 3,635.7 ± 1,592.3 0.376
Crystalloids 2,680.2 ± 1,153.8 2,862.0 ± 1,216.0 0.333
Colloids 724.7 ± 720.2 773.7 ± 664.6 0.656
FFP 141.5 ± 620.2 73.7 ± 252.4 0.369
PRBC 224.4 ± 1036.5 144.7 ± 371.6 0.521
Input total 3,770.8 ± 2,827.5 3,854.2 ± 1,954.2 0.829
Fluid balance 2,604.8 ± 2,051.1 2,813.3 ± 1,438.0 0.477
Fluids postoperatively (ml)
Blood loss 249.6 ± 388.8 268.4 ± 324.1 0.780
Urine output 1,679.7 ± 924.2 1,677.3 ± 1,134.6 0.990
Crystalloids + Colloids 3,598.8 ± 2,325.4 3,260.8 ± 2,104.7 0.425
Crystalloids 3,452.2 ± 2,283.2 3,204.2 ± 2,110.9 0.555
Colloids 146.6 ± 307.2 56.6 ± 211.7 0.078
FFP 34.3 ± 189.5 0 ± 0 0.191
PRBC 85.0 ± 379.4 44.8 ± 164.8 0.470
Input total 3,724.2 ± 2,584.2 3,296.0 ± 2,138.2 0.346
Fluid balance 1,724.9 ± 2,374.2 1,357.0 ± 1,871.6 0.373
Fluids total (ml)
Input 7,597.2 ± 4,906.3 7,053.2 ± 3,285.8 0.498
Crystalloids 6,031.5 ± 2,792.6 5,876.9 ± 2,598.2 0.764
Colloids 960.3 ± 862.7 962.6 ± 705.9 0.988
Balance 4,332.6 ± 3,715.7 3,956.5 ± 2,469.7 0.561
Data are mean ± SD. Data were compared using Student’s t-test. FFP, fresh frozen plasma; PRBC, packed red blood cells.
Table 3 Use of inotropes and vasopressors
Control group
(n = 81)
Study group
(n = 79)
P-value
Inotropes intraoperativelya
Dobutamine 0 33 <0.001
Vasopressors
intraoperativelya
Total 40 37 0.994
Norepinephrine 32 26 0.482
Phenylephrine 4 0 0.135
Ephedrine 8 11 0.584
Inotropes postoperativelya
Dobutamine 0 0 -
Vasopressors
postoperativelya
Norepinephrine 9 5 0.502
aNumber of patients.
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http://ccforum.com/content/17/5/R191Analysis of the predefined clustering of complications
showed that there was a significant difference in the sub-
group of infection complications (SG: 13 complications
versus CG: 26 complications, P = 0.023). Also the cluster
of abdominal complications showed a trend towards
fewer complications in the SG (22 complications versus
29 complications, P = 0.328), but without reaching sta-
tistical significance, as illustrated in Figure 3a.
We further analyzed the subgroup of patients who
received bowel surgery compared to non-bowel surgery.
The reduction in the number of patients with complica-
tions was particularly pronounced in the group of patients
receiving bowel surgery (SG: 12 complications versus CG:
24 patients, P = 0.003) compared to non-bowel surgery
(SG: 9 patients versus CG: 12 patients, P = 0.931), see
Figure 4. Analysis of clustering of complications showed
that the number of infection complications in patients
undergoing bowel surgery was significantly reduced (SG: 8
complications versus CG: 18 complication, P = 0.01).
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Figure 3 Postoperative complications. a) number of complications. b) number of patients with complications. * Significantly different between
control group and study group (P < 0.05).
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There were no significant differences in the return of
first bowel movement after surgery (SG: 3 (1) days
versus CG: 2 (1) days, P = 0.316) and the need for
enteral feeding postoperatively (SG: 5 patients versus
CG: 8 patients, P = 0.595). Further, there were no signifi-
cant differences in the duration of stay in the PACU
(SG: 180 (127.5) minutes versus CG: 180 (114) minutes,P = 0.516) or length of hospital stay (SG: 11 (8) days
versus CG: 10 (11.8) days, P = 0.929) in the two groups.Discussion
This is the first randomized multi-center study in patients
undergoing major abdominal surgery demonstrating that
perioperative hemodynamic GDT using PPV, radial artery
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a reduction in postoperative complications.
Several single-center studies and meta-analyses have
already pointed towards the benefit of perioperative
hemodynamic GDT on patient morbidity and mortality.
These diverse studies with different study protocols and
algorithms make comparison and common evaluation
very difficult. Furthermore, a single-center study always
has the potential limitation that it is performed by a
highly skilled study team – this, of course, strengthens
the quality of data; however, potentially it does not test
the adoption of the protocol into daily clinical practice.
Therefore, the intention of our study was to investigate
the influence of GDT in different medical centers in
different countries, with different local practices and a
broad range of different intra-abdominal procedures. In
order to keep this diversity and, therefore, allowing its
translation in daily clinical routine we did not dictate
treatment in the CG.
We chose postoperative complications as the primary
outcome parameter because the occurrence of 28-day
postoperative complications has been shown to be of
greater importance than preoperative patient risk and
intraoperative factors in determining survival after major
surgery [27]. Undoubtedly, length of hospital stay is one
important factor for the individual patient, as well as for
the healthcare system. However, it is obvious that it is af-
fected by many aspects besides postoperative complica-
tions, including patients’ preoperative fitness and health,
but also the social, structural and logistical aspects of
each individual patient and each health care system.
The study showed a significant decrease in the primary
endpoint (complications) for patients in the SG and alsoBowel surgery
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Figure 4 Number of patients with complications: bowel versus no bo
group (P < 0.05).a reduction in the number of patients with complications.
This strengthens the results of previous single-center
studies [4,5,23,24,28], current meta-analyses [29-31] and a
recently published Cochrane review [32]. The review ana-
lyzed randomized controlled single center trials on the
intervention of increasing perioperative blood flow using
fluids with or without inotropes or vasoactive drugs to
defined goals in adults. Results are very much in-line with
the results of the multi-center study presented here. There
was no difference in mortality between the CG and the
treatment group. However, the rate of renal failure,
respiratory failure and wound infections was signifi-
cantly reduced in the treatment group. Also, the num-
ber of patients with complications was significantly
reduced by the intervention [32].
In our study, in particular, infection complications
were significantly reduced in the SG. This is in line with
a recent meta-analysis demonstrating that perioperative
goal directed therapy resulted in a significantly reduced
number of surgical site infections, pneumonia and
urinary tract infections [33].
A further sub-analysis revealed that, in particular,
patients undergoing bowel surgery and treated by GDT
seemed to suffer significantly fewer complications. This
supports previous results where GDT was found to be of
great benefit especially in patients with bowel surgery
[4,5]. However, because the study design did not include
subgroup-analysis, the power of this study is not suffi-
cient to draw this final conclusion. Further research
needs to be directed at high risk patients undergoing
major, but not bowel, surgery.
Two very recent trials investigated the effects of GDT in
colorectal surgery with different results. Challand et al.No bowel surgery
Control group
Study group
wel surgery. * Significantly different between control group and study
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goal-directed versus standard fluid regimen with subgroups
of aerobically fit and unfit patients. They showed that for
aerobically fit patients, GDT was associated with no benefit
and even had detrimental effects on readiness for discharge
and length of hospital stay. We think the reason for these
conflicting results is the selection of patients and surgical
interventions. The subgroup of aerobically fit patients
consisted mainly of ASA 1 and 2 patients. In some cases
this results in a combination of a healthy, fit patient receiv-
ing low invasive and, in particular, laparoscopic surgery. In
these patients we would not expect there to be any great
advantages to GDT. That is why for this trial we chose only
to investigate major open abdominal surgery and to exclude
laparoscopic procedures and ASA 1 patients.
Brandstrup et al. [35] conducted a double-blinded,
multi-center trial with GDT versus zero fluid balance in
open and laparoscopic colorectal surgery showing no
differences in length of hospital stay or complications.
Again, mostly ASA 1 and 2 patients and also patients
undergoing laparoscopic surgery were included.
In our study, although patients from both groups
received nearly the same net amount of fluids
perioperatively, and also the number of patients being
treated with vasopressors intraoperatively was not signifi-
cantly different between the two groups, 41.8% of patients
in the SG received inotropes compared to none in the CG.
This is not surprising as the use of inotropes was part of
the algorithm for the GDT. As there was no monitoring
of CI in the CG, on what could physicians base the
decision to use inotropes? In an earlier study, Pearse et al.
[28], showed a reduction in postoperative complications
after the use of GDT postoperatively owing to an increase
in global oxygen delivery through volume optimization
and inotropic therapy. The authors suggested that through
an increase in tissue partial pressure of oxygen there was
improved tissue healing and, therefore, a reduction in
infection rates. These suggestions are supported by our
results. We did not measure oxygen demand or the tissue
partial pressure of oxygen but our algorithm was aimed at
optimizing intravascular volume and CI resulting in the
same effect of improved tissue perfusion and oxygenation.
A currently published meta-analysis could not identify
evidence for an increased risk of treatment-related cardiac
complications following the use of inotropes due to GDT
[36], but it is important to note that, if the indication for
inotropes is increased on the basis of these findings,
special attention will be necessary in high-risk cardiac
patients, where current clinical guidelines recommend
perioperative ß-blockade as cardioprotection [37]. Al-
though we did not recognize any signs of postoperative
myocardial infarction in our patients, further research
needs to be directed at this growing subgroup of surgical
patients.Detailed analysis of intraoperative hemodynamic para-
meters suggests that the timing of fluid loading was better
in the SG, as the MAP was significantly higher at four time
points of measurement (30, 45, 120 and 150 minutes). This
was also the case immediately after arrival at the PACU.
These intra- and postoperative data suggest that if there is
no algorithm, therapy is undirected and may be delayed
because of the anesthesiologists’ fear of fluid overload with
its potential harmful consequences.
Measurements of PPV and pulse contour CI were
taken via a regular radial arterial line although validation
studies of similar devices for monitoring CI have shown
varying results. However, although this technique may
not provide optimal precision, the CI trending ability
seems to be sufficient [12,13,18,38]. The clinical use-
fulness in hemodynamically stable patients undergoing
major surgery is strengthened by the present data. How-
ever, if large amounts of blood loss with severe hemo-
dynamic instability are anticipated during the course of
surgery, as for example during major vascular surgery or
liver transplant, or if the patient is at high risk due to
comorbidities, we would recommend additional and more
precise monitoring devices for these patients, in terms of
a stepwise extension of hemodynamic monitoring.
The intervention in this study, that is, the modification
of hemodynamic therapy, was initialized intraoperatively.
The rationale was to initiate ‘earliest goal directed ther-
apy’ to maximize the treatment benefit for the whole
perioperative course of the patients.
There are several limitations to this study: Only the
patients were blinded to their group allocation. Physi-
cians, nurses and investigators could not be blinded
because of the use of PPV and CI monitoring and the
corresponding algorithms. Furthermore, we decided to
omit any additional monitoring in the CG to guarantee
that no PPV or CI information could be obtained from
the treating anesthesiologist. Certainly, it would have
been of interest to have these data for comparison with
the SG as well. Since CG care was entirely performed on
the discretion of the care-giving anesthesiologist, we
assume that CG care was adequate according to clinical
expertise and local standards in the participating institu-
tions, which are all high-volume university centers. Of
course, we cannot fully eliminate the possibility that the
difference in outcomes is not due to benefit in the inter-
vention group but due to poor care in the CG. Sample
size calculation was based on the reduction of the total
number of complications, which was adopted from
earlier studies in this field. We also analyzed the number
of patients with complications since this might have
been more relevant due to the fact that one patient may
develop a large number of complications if they develop
multi-organ failure. Further, this study cannot answer
the question: is the algorithm proposed here, adding an
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suggested treatment algorithms? This needs to be
answered in future trials. Finally, the results of this study
are not transferrable to all patients undergoing major
abdominal surgery, since arterial pulse contour analysis
and the determination of PPV only works reliably in
patients without severe arrhythmias and under fully
controlled ventilation.
Conclusions
In conclusion, this is the first randomized multi-center
study on perioperative hemodynamic GDT for patients
undergoing major abdominal surgery. The results sup-
port a goal-directed therapy approach in order to reduce
complications and, therefore, patient morbidity.
Key messages
 The perioperative use of an algorithm for
hemodynamic therapy, based on radial artery pulse
contour analysis leads to a reduction of
postoperative complications in patients undergoing
intra-abdominal surgery.
 The net amount of fluid and volume application is
not increased by the application of a goal-directed
hemodynamic algorithm based on PPV, CI and
MAP.
 The proposed algorithm-driven hemodynamic
optimization induced in some patients the additional
application of inotropes. It needs to be clarified in
future studies, if this application contributed to the
reduction in complications.
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